Quijano, Averie M.
HRN: 24-36-78 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/22/2024
AMPICILLIN 250MG (VIAL)
01/22/2024
01/28/2024
IV
90mg
Q8
Ophthalmia Neonatorum
Waiting Final Action
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes